Annual CFO
-$21.23 M
+$2.52 M+10.61%
December 31, 2023
Summary
- As of February 7, 2025, KRBP annual cash flow from operations is -$21.23 million, with the most recent change of +$2.52 million (+10.61%) on December 31, 2023.
- During the last 3 years, KRBP annual CFO has fallen by -$15.10 million (-246.45%).
- KRBP annual CFO is now -885.89% below its all-time high of -$2.15 million, reached on December 31, 2018.
Performance
KRBP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$1.93 M
+$6.25 M+76.39%
September 30, 2024
Summary
- As of February 7, 2025, KRBP quarterly cash flow from operations is -$1.93 million, with the most recent change of +$6.25 million (+76.39%) on September 30, 2024.
- Over the past year, KRBP quarterly CFO has increased by +$6.25 million (+76.39%).
- KRBP quarterly CFO is now -1041.93% below its all-time high of -$169.10 thousand, reached on June 30, 2019.
Performance
KRBP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$21.22 M
+$3.30 M+13.44%
September 30, 2024
Summary
- As of February 7, 2025, KRBP TTM cash flow from operations is -$21.22 million, with the most recent change of +$3.30 million (+13.44%) on September 30, 2024.
- Over the past year, KRBP TTM CFO has increased by +$3.30 million (+13.44%).
- KRBP TTM CFO is now -9073.93% below its all-time high of -$231.30 thousand, reached on March 31, 2019.
Performance
KRBP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
KRBP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.6% | +76.4% | +13.4% |
| 3 y3 years | -246.4% | +70.1% | -2.1% |
| 5 y5 years | -885.9% | +70.1% | -2.1% |
KRBP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -4.5% | +10.6% | at high | +78.9% | -6.5% | +26.3% |
| 5 y | 5-year | -628.4% | +10.6% | -102.5% | +78.9% | -628.2% | +26.3% |
| alltime | all time | -885.9% | +10.6% | -1041.9% | +78.9% | -9073.9% | +26.3% |
Kiromic BioPharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.93 M(-76.4%) | -$21.22 M(-13.4%) |
| Jun 2024 | - | -$8.18 M(+43.5%) | -$24.52 M(+7.5%) |
| Mar 2024 | - | -$5.70 M(+5.4%) | -$22.80 M(+7.4%) |
| Dec 2023 | -$21.23 M(-10.6%) | -$5.41 M(+3.5%) | -$21.23 M(+6.6%) |
| Sep 2023 | - | -$5.23 M(-19.1%) | -$19.92 M(-4.2%) |
| Jun 2023 | - | -$6.46 M(+56.5%) | -$20.79 M(+2.4%) |
| Mar 2023 | - | -$4.13 M(+0.6%) | -$20.30 M(-14.5%) |
| Dec 2022 | -$23.75 M(+16.9%) | -$4.10 M(-32.7%) | -$23.75 M(-17.6%) |
| Sep 2022 | - | -$6.10 M(+2.1%) | -$28.81 M(+4.7%) |
| Jun 2022 | - | -$5.97 M(-21.2%) | -$27.53 M(+8.9%) |
| Mar 2022 | - | -$7.58 M(-17.3%) | -$25.26 M(+24.3%) |
| Dec 2021 | -$20.32 M | -$9.17 M(+90.5%) | -$20.32 M(+48.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$4.81 M(+29.8%) | -$13.73 M(+39.1%) |
| Jun 2021 | - | -$3.71 M(+40.7%) | -$9.87 M(+35.5%) |
| Mar 2021 | - | -$2.64 M(+2.6%) | -$7.28 M(+18.9%) |
| Dec 2020 | -$6.13 M(+110.3%) | -$2.57 M(+169.5%) | -$6.13 M(+12.0%) |
| Sep 2020 | - | -$953.40 K(-15.1%) | -$5.47 M(+6.9%) |
| Jun 2020 | - | -$1.12 M(-24.1%) | -$5.12 M(+22.9%) |
| Mar 2020 | - | -$1.48 M(-22.6%) | -$4.16 M(+42.9%) |
| Dec 2019 | -$2.91 M(+35.3%) | -$1.91 M(+218.6%) | -$2.91 M(+191.1%) |
| Sep 2019 | - | -$600.50 K(+255.1%) | -$1.00 M(+150.0%) |
| Jun 2019 | - | -$169.10 K(-26.9%) | -$400.40 K(+73.1%) |
| Mar 2019 | - | -$231.30 K | -$231.30 K |
| Dec 2018 | -$2.15 M | - | - |
FAQ
- What is Kiromic BioPharma annual cash flow from operations?
- What is the all time high annual CFO for Kiromic BioPharma?
- What is Kiromic BioPharma annual CFO year-on-year change?
- What is Kiromic BioPharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly CFO year-on-year change?
- What is Kiromic BioPharma TTM cash flow from operations?
- What is the all time high TTM CFO for Kiromic BioPharma?
- What is Kiromic BioPharma TTM CFO year-on-year change?
What is Kiromic BioPharma annual cash flow from operations?
The current annual CFO of KRBP is -$21.23 M
What is the all time high annual CFO for Kiromic BioPharma?
Kiromic BioPharma all-time high annual cash flow from operations is -$2.15 M
What is Kiromic BioPharma annual CFO year-on-year change?
Over the past year, KRBP annual cash flow from operations has changed by +$2.52 M (+10.61%)
What is Kiromic BioPharma quarterly cash flow from operations?
The current quarterly CFO of KRBP is -$1.93 M
What is the all time high quarterly CFO for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly cash flow from operations is -$169.10 K
What is Kiromic BioPharma quarterly CFO year-on-year change?
Over the past year, KRBP quarterly cash flow from operations has changed by +$6.25 M (+76.39%)
What is Kiromic BioPharma TTM cash flow from operations?
The current TTM CFO of KRBP is -$21.22 M
What is the all time high TTM CFO for Kiromic BioPharma?
Kiromic BioPharma all-time high TTM cash flow from operations is -$231.30 K
What is Kiromic BioPharma TTM CFO year-on-year change?
Over the past year, KRBP TTM cash flow from operations has changed by +$3.30 M (+13.44%)